The estimated Net Worth of L John Wilkerson is at least $201 Mille dollars as of 31 July 2022. John Wilkerson owns over 11,660 units of Quotient Ltd stock worth over $40,515 and over the last 22 years he sold QTNT stock worth over $0. In addition, he makes $159,998 as Independent Director at Quotient Ltd.
Sign up
John Wilkerson QTNT stock SEC Form 4 insiders trading
John has made over 17 trades of the Quotient Ltd stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 11,660 units of QTNT stock worth $4,431 on 31 July 2022.
The largest trade he's ever made was buying 4,666,666 units of Quotient Ltd stock on 24 June 2022 worth over $1,400,000. On average, John trades about 172,921 units every 88 days since 2003. As of 31 July 2022 he still owns at least 106,618 units of Quotient Ltd stock.
You can see the complete history of John Wilkerson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Wilkerson biography
Dr. John Wilkerson serves as Independent Director of the Company. Dr. Wilkerson co-founded Galen Partners in 1990 and currently serves as a Senior Advisor to Galen. Dr. Wilkerson has focused on healthcare throughout his career, beginning as a Group Product Director for Ortho-Clinical Diagnostics Inc. He was a Vice President covering medical device companies at Smith Barney before moving in 1980 to Channing, Weinberg & Co., Inc., a management consulting firm for pharmaceutical, diagnostic, medical device and biotechnology companies, which he acquired and renamed The Wilkerson Group. The Wilkerson Group was subsequently acquired by IBM in 1996. Dr. Wilkerson was previously a director of Sonacare Medical and was the Chairman of Atlantic Health Systems, a New Jersey hospital system. He is a trustee and former President of the Museum of American Folk Art and founder of the E.L. Rose Conservancy. Dr. Wilkerson received a Ph.D. from Cornell University.
What is the salary of John Wilkerson?
As the Independent Director of Quotient Ltd, the total compensation of John Wilkerson at Quotient Ltd is $159,998. There are 8 executives at Quotient Ltd getting paid more, with Franz Walt having the highest compensation of $2,290,340.
How old is John Wilkerson?
John Wilkerson is 77, he's been the Independent Director of Quotient Ltd since 2012. There are no older and 14 younger executives at Quotient Ltd.
What's John Wilkerson's mailing address?
L's mailing address filed with the SEC is C/O GALEN PARTNERS,, 680 WASHINGTON BLVD, STAMFORD, CT, 06901.
Insiders trading at Quotient Ltd
Over the last 11 years, insiders at Quotient Ltd have traded over $5,237,327 worth of Quotient Ltd stock and bought 21,364,813 units worth $72,052,006 . The most active insiders traders include Advisors Llcperceptive Life..., Zubeen Shroff e L John Wilkerson. On average, Quotient Ltd executives and independent directors trade stock every 15 days with the average trade being worth of $57,203. The most recent stock trade was executed by Catherine Larue on 31 January 2023, trading 438 units of QTNT stock currently worth $166.
What does Quotient Ltd's logo look like?
Complete history of John Wilkerson stock trades at Quotient Ltd e Stericycle
Quotient Ltd executives and stock owners
Quotient Ltd executives and other stock owners filed with the SEC include:
-
Franz Walt,
Chief Executive Officer, Director -
Edward Farrell,
Chief Operating Officer -
Jeremy Stackawitz,
Chief Commercial Officer -
Peter Buhler,
Chief Financial Officer -
Heino.N.F.M von Prondzynski,
Independent Chairman of the Board -
Frederick Hallsworth,
Independent Director -
Brian McDonough,
Independent Director -
Zubeen Shroff,
Independent Director -
John Wilkerson,
Independent Director -
Catherine Larue,
Independent Director -
Isabelle Buckle,
Independent Director -
Ernest Larnach,
Head - Financial Accounting & Treasury -
Esteban Uriarte,
Chief Manufacturing Operations Officer -
Mohammad El Khoury,
Chief Commercial Officer -
Christian Albrich,
Chief People Officer -
Dr. Christine Ginocchio,
Chief Scientific & Medical Officer -
Dr. Michael Hausmann,
Chief Technology Officer -
Vittoria Bonasso,
Head of Fin., Group Controller & Principal Accounting Officer -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
CEO & Director -
Ernest Larnach,
Head of Financial Accounting & Treasury -
Vittoria Bonasso,
See Remarks -
Roland Boyd,
See Remarks -
Thomas A Bologna,
Director -
Sarah A Oconnor,
Director -
Stephen Unger,
Chief Financial Officer -
Partners V Lp Galen Partner...,
-
Deidre Quotient Biodiagnost...,
-
D J Paul E Cowan,
See Remarks -
Sophie Bechu,
Director -
Advisors Llcperceptive Life...,
-
Christopher J Lindop,
EVP -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
Chief Executive Officer -
Khoury Mohammad El,
Chief Commercial Officer -
Thomas Aebischer,
Director